Sponsor Pipeline

Atea Pharmaceuticals, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
2
Recruiting
2
Phase 3
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-01 NCT06911320
Study of Bemnifosbuvir/Ruzasvir as a Fixed-dose Combination in Subjects With Normal or…		 Trial completed
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-07-27 NCT07728487 Study of AT-587 in Healthy Subjects Phase 1 Recruiting
Active Trials by Phase
Phase 3
2
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06868264 C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV HEPATITIS C VIRUS CHRONIC INFECTION Active, Not Recruiting
NCT07037277 C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV HEPATITIS C VIRUS CHRONIC INFECTION Active, Not Recruiting
Phase 1
NCT07314346 Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and… Healthy Volunteer Study Recruiting
NCT07728487 Study of AT-587 in Healthy Subjects Hepatitis E Recruiting
Get alerts when Atea Pharmaceuticals, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free